TrialThe oncologist2022

Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.

Niven Mehra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.